NeuroReality
NeuroReality is a Netherlands-based medtech company that developed Koji's Quest, a CE marked VR platform delivering gamified cognitive rehabilitation for stroke, long-COVID, traumatic brain injury, and dementia patients. Acquired by XRHealth in November 2024.
- Company typePrivate
- Founded2017
- HeadquartersAmsterdam, Netherlands
- Headcount1–10
- GTM typeB2B and B2C
- OfferingSoftware
What NeuroReality does
NeuroReality B.V. is an Amsterdam-based medtech company founded in 2017 by Faviola Dadis, who identified gaps in continued cognitive care after a family member's stroke. Its flagship product, Koji's Quest, is a CE marked Class I medical device delivered as a VR-based serious game that combines neuroscientific principles with gamification and adaptive difficulty algorithms to provide customizable cognitive rehabilitation. The platform features six training modules — Mystical Lake (multitasking/prioritization), Mayan Temple (visuospatial reasoning), Nautilus Underwater Memory (memory training), Crystal Calculation Forest (mathematical skills), Galactic Diamond Belt (selective attention), and Alien Outpost (divided attention) — plus a Garden of Zen mindfulness area and a Koji virtual companion for guided, independent at-home training. A multi-sensory 6DoF experience is used to increase ecological validity and transfer of training effects to daily life.
The product addresses cognitive deficits across attention, memory, executive functioning, visuospatial skills, and numerical manipulation for patients with stroke, long-COVID, traumatic brain injury, dementia, neurodevelopmental conditions, and healthy aging populations. The company's go-to-market combines product-led growth (2-month free pilot trial for clinicians and patients, license purchase thereafter) with B2B distribution through the XRHealth virtual clinic platform (covering USA, Europe, Australia, and Israel) and the SyncVR Medical VR Health App Store, supplemented by direct demo bookings and Dutch-government-supported trade mission participation for US expansion. Knowledge partners include Radboudumc, Universiteit Utrecht, UvA, HvA, VU Amsterdam, Heliomare, and patient advocacy organization Hersenletsel.nl. The organization operates with 1-10 employees out of Amsterdam with a secondary presence at the Murrieta Innovation Center in California, and was acquired by Boston-based XRHealth in November 2024.
NeuroReality firmographics
Firmographics- Name
- NeuroReality
- Legal name
- NeuroReality B.V.
- Website
- https://neuro-reality.com
- Company type
- Private
- Founded year
- 2017
- Operating status
- Acquired
- Headcount range
- 1–10 employees
- Short description
- NeuroReality is a Netherlands-based medtech company that developed Koji's Quest, a CE marked VR platform delivering gamified cognitive rehabilitation for stroke, long-COVID, traumatic brain injury, and dementia patients. Acquired by XRHealth in November 2024.
- Ownership category
- akta.pro rank
NeuroReality industry classification
Industry- Product category
- VR Cognitive Rehabilitation Software
- NAICS
- Educational Support Services (61171), Other Computer Related Services (541519)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Behavioral Health & Neurocognitive Therapeutics (Digital) (HLACANAI)
- akta.pro secondary industry
- Cognitive Stimulation & Reminiscence Therapy (Non-Clinical) (HSABAEAH)
Keywords
Where NeuroReality is headquartered
LocationHeadquarters
- HQ city
- Amsterdam
- HQ country
- Netherlands
- HQ region
- Europe
Offices2 records
Markets served
NeuroReality business model
Business model- GTM type
- B2B and B2C
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations
Revenue model
- Software Licensing: Koji's Quest is offered as a downloadable software license. Users must purchase a copy of the Software to access the game and system. The EULA indicates licensing model with accounts for individual users, with potential for business arrangements through direct contact with NeuroReality.
- License Subscriptions (implied): NeuroReality offers a 2-month free trial period for both patients and clinicians to experience Koji's Quest before purchasing. After the trial, users choose their preferred license to continue using the product.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Multi-year contract | Standard License (perpetual) |
| Freemium | Pay-as-you-go | Free Trial (2 months) |
Go-to-market motion3 records
Distribution channels4 records
Marketing channels6 records
NeuroReality product offering
Product offeringCore offering
NeuroReality develops and sells Koji's Quest, a CE marked Class I medical VR-based serious game that delivers customizable cognitive rehabilitation for stroke, long-COVID, traumatic brain injury, dementia, and acquired brain injury patients. The platform combines neuroscientific principles, gamification, and smart adaptive algorithms across six cognitive training modules covering attention, memory, executive functioning, visuospatial reasoning, and numerical skills, with remote clinician monitoring and at-home training support via a virtual companion.
Product overview
NeuroReality offers a single flagship product, Koji's Quest, a VR-based cognitive rehabilitation serious game. The platform provides customizable rehabilitation programs through gamified experiences, targeting cognitive functions including attention, memory, executive functioning, visuospatial abilities, and numerical skills. Koji's Quest is complemented by NeuroNow, a content platform for research insights and company updates. The product is CE marked as a Class I medical device and is distributed through partnerships with XRHealth virtual clinics and the SyncVR Medical VR Health App Store.
Differentiator
Problem solved
Functional benefit
Brands
- Koji's Quest: VR-based serious game for cognitive rehabilitation combining neuroscientific principles, gamification, and smart algorithms for customizable rehabilitation programs targeting stroke, long-COVID, traumatic brain injury, and dementia patients.
Products and services
- Koji's Quest A CE marked Class I medical device VR-based serious game that combines neuroscientific principles, gamification, and smart adaptive algorithms to deliver customizable cognitive rehabilitation for stroke, long-COVID, traumatic brain injury, dementia, and other acquired brain injury patients. Includes six cognitive training modules (Mystical Lake, Mayan Temple, Nautilus Underwater Memory, Crystal Calculation Forest, Galactic Diamond Belt, Alien Outpost), a virtual companion (Koji), an integrated Garden of Zen mindfulness area, remote clinician monitoring, and 6DoF immersive training on compatible VR headsets. Targets clinicians, healthcare providers, and individual patients/caregivers.
Quantifiable outcome
- 400 million+ acquired brain injury patients worldwide suffer from long-term cognitive problems that Koji's Quest can address
- +2 more outcomes
Companies that use NeuroReality
Customer profileNamed customers2 records
Segments7 records
Ideal customer profiles2 records
NeuroReality technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
AI capability2 records
Feature7 records
NeuroReality partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered core, strategic and minor.
- XRHealthcoreXRHealth, a Boston-based virtual clinic providing medical and therapeutic treatments via telehealth, added NeuroReality's Koji's Quest to their virtual clinics. XRHealth distributes applications in the USA, Europe, Australia, and Israel. The integration allows clinicians to prescribe Koji's Quest within the XRHealth platform, with real-time patient data monitoring.
- Dutch Government / RVOstrategicNeuroReality participated in the Dutch Royal Trade Mission to California (September 5-9, 2022), organized by the Dutch government. The mission connected the company with approximately 100 Dutch companies in healthtech and urban mobility, and US-based potential partners, clients, and investors. CEO Sandy Rathod represented the company alongside Her Majesty Maxima and government officials.
- RadboudumcstrategicRadboudumc collaborated with SyncVR Medical, Reducept and NeuroReality on the COVID Virtual Rehabilitation program called FitterVandaagVR. NeuroReality contributed cognitive training modules to the rehabilitation program, which also included pain management and movement exercises. Patients rehabilitate using tetherless VR devices from their own homes.
- SyncVR MedicalminorSyncVR Medical launched the first VR Health App Store, centralizing VR healthcare technology. NeuroReality's Koji's Quest is available through this marketplace alongside other VR healthcare applications for cognitive rehabilitation.
- ReduceptminorCollaborated with NeuroReality and other partners on the COVID Virtual Rehabilitation program FitterVandaagVR, contributing to comprehensive VR-based rehabilitation solutions.
- Murrieta Innovation CenterminorNeuroReality became an international tenant at the Murrieta Innovation Center in California in September 2023, establishing a presence in the US market as part of their expansion strategy.
- Knowledge Partners and ClinicscoreNeuroReality works with knowledge partners and clinics worldwide to offer cognitive rehabilitation. Partners include academic institutions (Universiteit Utrecht, UvA, HvA, VU Amsterdam), healthcare organizations (Heliomare, Hersenletsel.nl), and technology companies to provide cognitive rehabilitation globally.
Scale indicators5 records
Recent moves6 records
Expansion highlights6 records
NeuroReality competitors and assessment
Company assessmentDirect peers
- Akili Interactive: US digital therapeutics company with FDA-cleared software (EndeavorRx) for cognitive deficits including ADHD and post-COVID brain fog. Closest US-listed analogue to NeuroReality in combining gamified software with regulatory clearance for cognitive rehabilitation indications.
- XRHealth: Boston-based virtual clinic platform that distributed and ultimately acquired NeuroReality. Operates a clinician-prescribed XR therapeutics platform overlapping directly with Koji's Quest in VR-based cognitive and physical rehabilitation for stroke, TBI, and other neurological conditions.
- MindMaze: Swiss-based digital neurotherapeutics company building VR and gamified platforms for neurological recovery, including stroke and brain injury rehabilitation. Directly comparable in clinical scope, regulatory positioning (CE-marked / FDA-cleared products), and target patient population.
- Constant Therapy Health (Linus Health): Digital cognitive and speech therapy platform used by clinicians for stroke and TBI rehabilitation. Overlaps with Koji's Quest on evidence-based cognitive rehabilitation for acquired brain injury, but delivered via tablet/web rather than VR.
- BehaVR: US VR digital therapeutics company developing prescription immersive therapies for mental health, chronic pain, and oncology — competes for the same clinician-prescribed VR therapy channel that NeuroReality targets through XRHealth.
- Reducept: Dutch VR digital therapeutics company focused on chronic pain management. Collaborated with NeuroReality on the FitterVandaagVR COVID rehab program and competes in the same European clinician-prescribed VR therapeutics market.
- SyncVR Medical: Dutch distributor of VR healthcare applications, including Koji's Quest via its SyncVR Medical VR Health App Store. Comparable as a European VR-health platform and a peer in distributing clinician-facing VR content across multiple therapeutic areas.
Emerging players
- Pear Therapeutics: Pioneer in FDA-authorized prescription digital therapeutics, including for schizophrenia and substance use disorder. Serves as a benchmark for the regulatory and commercial pathway NeuroReality would need to follow to scale prescription digital therapeutics in the US, even though Pear filed for bankruptcy in 2023.
- CogniFit: Consumer and clinical brain-training platform offering cognitive assessment and training across multiple domains. Comparable in cognitive-domain coverage but lacks immersive VR delivery and is more focused on assessment and wellness than on certified medical-device rehabilitation.
Broad incumbents
- Saebo: Established US provider of stroke and neurological rehabilitation products and digital therapy tools. Competes for the same clinician budget and patient population as Koji's Quest, but from a broader physical-occupational-therapy product portfolio.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks1 record
Key highlights7 records
Customer concentration
NeuroReality social profiles
Digital presenceNeuroReality compliance and trust
Trust signalCompliance1 record
NeuroReality financial estimates
Financial estimateRevenue estimate
Valuation estimate
NeuroReality leadership team
Management profileNumber of profiles
Profiles7 records
NeuroReality funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
NeuroReality M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about NeuroReality
What does NeuroReality do?
NeuroReality develops and sells Koji's Quest, a CE marked Class I medical VR-based serious game that delivers customizable cognitive rehabilitation for stroke, long-COVID, traumatic brain injury, dementia, and acquired brain injury patients. The platform combines neuroscientific principles, gamification, and smart adaptive algorithms across six cognitive training modules covering attention, memory, executive functioning, visuospatial reasoning, and numerical skills, with remote clinician monitoring and at-home training support via a virtual companion.
Is NeuroReality a public or private company?
NeuroReality is a private company. It is classified as corporate owned and is currently acquired.
When was NeuroReality founded?
NeuroReality was founded in 2017. It employs 1 to 10 people.
Where is NeuroReality based?
NeuroReality is headquartered in Amsterdam, Netherlands, in the Europe region.
How does NeuroReality make money?
Two revenue lines are on record. Software Licensing is the primary driver. The others are license Subscriptions (implied).
Who are NeuroReality's main competitors?
Direct peers on record are Akili Interactive, XRHealth, MindMaze, Constant Therapy Health (Linus Health), BehaVR, Reducept and SyncVR Medical. Emerging players are Pear Therapeutics and CogniFit. Saebo is listed as a broad incumbent.
Does NeuroReality have an API?
No public API is recorded for NeuroReality.
What industry is NeuroReality in?
NeuroReality's product category is VR Cognitive Rehabilitation Software. Its primary akta.pro industry code is HLACANAI, Behavioral Health & Neurocognitive Therapeutics (Digital), with a secondary code of HSABAEAH, Cognitive Stimulation & Reminiscence Therapy (Non-Clinical). Its NAICS code is 61171 and its SIC code is 7372.